May. 14 at 3:29 PM
$TARA I'd say the shelf is probably bullish. Since the company has cash into 2028, it isn't looking to raise now. The shelf pre-registers securities that "can" be sold over the next 3 years. TARA has some major catalysts scheduled during that time-frame. It'll be poised to act when the iron is hot....likely next year. With LM poised to move into late trial status, the unresponsive NMIBC group getting fully enrolled ...the start of the Naive pivotal trial, choline chloride results later this year, the stock price could see some real movement before that shelf would be tapped. Thus far, TARA has shown nothing but positive results from its lead compound(s). JMO
